-
Your selected location is
Middle East / Africa
- Change location/language
Old Browser
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Overview
Cell therapy research is a rapidly advancing field. Multiple cell therapies are now commercially available across the world to treat certain hematological disorders. A plethora of clinical trials for investigational therapies addressing a wide range of diseases like cancer, autoimmune disease and genetic disorders are using autologous or allogeneic cells with rapidly evolving cell engineering and editing approaches. A common theme in cell therapy research is the need to understand cell phenotypes and heterogeneity at every step of the process, including characterization and development of predictive biomarkers and cells isolated from patients as input for cell therapy manufacturing.
Flow cytometry is a powerful tool to characterize cell phenotypes to define critical quality attributes for cell therapy products such as cell viability, identity, potency and purity. Flow cytometry assays are performed at different stages during the development and manufacturing of cell therapy products. Assays are often transferred between multiple manufacturing sites for the final release and QC of therapeutic products.
A Flow Cytometry Partner
at Every Level
Cell and gene therapy research is a rapidly advancing field. Multiple cell and gene therapies are now commercially available across the world to treat certain hematological disorders. A plethora of clinical trials for investigational therapies addressing a wide range of diseases like cancer, autoimmune disease and genetic disorders are using autologous or allogeneic cells with rapidly evolving cell engineering and editing approaches. A common theme in cell and gene therapy research is the need to understand cell phenotypes and heterogeneity at every step of the process, including characterization and development of predictive biomarkers and cells isolated from patients as input for cell therapy manufacturing.
Flow cytometry is a powerful tool to characterize cell phenotypes to define critical quality attributes for cell and gene therapy products such as cell viability, identity, potency and purity. Flow cytometry assays are performed at different stages during the development and manufacturing of cell therapy products. Assays are often transferred between multiple manufacturing sites for the final release and QC of therapeutic products.
BD Biosciences is your global partner in single-cell analysis. We provide extensive scientific resources and tools that enable high-dimensional analysis, automation and standardization because we are committed to partnering with you so that you can advance your cell therapy research programs by delivering high-quality solutions that support your 21 CFR Part 11 compliance.